These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 9381703)

  • 21. Ifosfamide nephrotoxicity in children: histopathological features in two cases.
    Morland BJ; Mann JR; Milford DV; Raafat F; Stevens MC
    Med Pediatr Oncol; 1996 Jul; 27(1):57-61. PubMed ID: 8614393
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A phase III trial of ifosfamide with or without cisplatin in carcinosarcoma of the uterus: A Gynecologic Oncology Group Study.
    Sutton G; Brunetto VL; Kilgore L; Soper JT; McGehee R; Olt G; Lentz SS; Sorosky J; Hsiu JG
    Gynecol Oncol; 2000 Nov; 79(2):147-53. PubMed ID: 11063636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Testicular function in poor-risk nonseminomatous germ cell tumors treated with methotrexate, paclitaxel, ifosfamide, and cisplatin combination chemotherapy.
    Pectasides D; Pectasides E; Papaxoinis G; Skondra M; Gerostathou M; Karageorgopoulou S; Kamposioras C; Tountas N; Koumarianou A; Psyrri A; Macheras A; Economopoulos T
    J Androl; 2009; 30(3):280-6. PubMed ID: 19136393
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Nephrotoxicity of antineoplastic drugs].
    Suzuki T; Nosaka K
    Ryoikibetsu Shokogun Shirizu; 1997; (16 Pt 1):542-6. PubMed ID: 9277811
    [No Abstract]   [Full Text] [Related]  

  • 25. Acute changes in urine protein excretion may predict chronic ifosfamide nephrotoxicity: a preliminary observation.
    MacLean FR; Skinner R; Hall AG; English M; Pearson AD
    Cancer Chemother Pharmacol; 1998; 41(5):413-6. PubMed ID: 9523738
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic ifosfamide nephrotoxicity in children.
    Skinner R
    Med Pediatr Oncol; 2003 Sep; 41(3):190-7. PubMed ID: 12868118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Cancer Study Group.
    Schmoll HJ; Kollmannsberger C; Metzner B; Hartmann JT; Schleucher N; Schöffski P; Schleicher J; Rick O; Beyer J; Hossfeld D; Kanz L; Berdel WE; Andreesen R; Bokemeyer C;
    J Clin Oncol; 2003 Nov; 21(22):4083-91. PubMed ID: 14568987
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ifosfamide nephrotoxicity in pediatric cancer patients.
    Lee BS; Lee JH; Kang HG; Hahn H; Lee JH; Shin HY; Ha IS; Cheong HI; Ahn HS; Choi Y
    Pediatr Nephrol; 2001 Oct; 16(10):796-9. PubMed ID: 11605785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effects of fractionated low dose Cisplatin on renal functions of patients with gastric carcinoma].
    Li Y; Shen L; Li J; Jin ML
    Ai Zheng; 2007 Dec; 26(12):1354-6. PubMed ID: 18076800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Obstructed versus dilated nonobstructed kidneys in children with congenital ureteropelvic junction narrowing: role of urinary tubular enzymes.
    Taha MA; Shokeir AA; Osman HG; Abd El-Aziz Ael-A; Farahat SE
    J Urol; 2007 Aug; 178(2):640-6. PubMed ID: 17574624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nephrotoxicity after high-dose carboplatin, etoposide and ifosfamide in germ-cell tumors: incidence and implications for hematologic recovery and clinical outcome.
    Beyer J; Rick O; Weinknecht S; Kingreen D; Lenz K; Siegert W
    Bone Marrow Transplant; 1997 Nov; 20(10):813-9. PubMed ID: 9404920
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renal failure does not preclude cure in children receiving chemotherapy for Wilms tumor: a report from the National Wilms Tumor Study Group.
    Feusner JH; Ritchey ML; Norkool PA; Takashima JR; Breslow NE; Green DM
    Pediatr Blood Cancer; 2008 Feb; 50(2):242-5. PubMed ID: 17458877
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase I/II dose escalation study of recombinant human interleukin-11 following ifosfamide, carboplatin and etoposide in children, adolescents and young adults with solid tumours or lymphoma: a clinical, haematological and biological study.
    Cairo MS; Davenport V; Bessmertny O; Goldman SC; Berg SL; Kreissman SG; Laver J; Shen V; Secola R; van de Ven C; Reaman GH
    Br J Haematol; 2005 Jan; 128(1):49-58. PubMed ID: 15606549
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Saline, mannitol, and furosemide hydration in acute cisplatin nephrotoxicity: a randomized trial.
    Santoso JT; Lucci JA; Coleman RL; Schafer I; Hannigan EV
    Cancer Chemother Pharmacol; 2003 Jul; 52(1):13-8. PubMed ID: 12719883
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cisplatin and carboplatin-induced ototoxicity in children: clinical aspects and perspectives for prevention].
    Montaguti M; Brandolini C; Ferri GG; Hatzopoulos S; Prete A; Pession A
    Acta Otorhinolaryngol Ital; 2002 Feb; 22(1):14-8. PubMed ID: 12236007
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extract of Prunus persica flesh (PPFE) improves chemotherapeutic efficacy and protects against nephrotoxicity in cisplatin-treated mice.
    Lee CK; Park KK; Hwang JK; Lee SK; Chung WY
    Phytother Res; 2009 Jul; 23(7):999-1005. PubMed ID: 19140122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Paclitaxel, ifosfamide, and nedaplatin (TIN) salvage chemotherapy for patients with advanced germ cell tumors.
    Nonomura N; Oka D; Nishimura K; Nakayama M; Inoue H; Mizutani Y; Miki T; Okuyama A
    Int J Urol; 2007 Jun; 14(6):527-31. PubMed ID: 17593098
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized comparison of combination chemotherapy with etoposide, bleomycin, and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors: a pediatric intergroup study--Pediatric Oncology Group 9049 and Children's Cancer Group 8882.
    Cushing B; Giller R; Cullen JW; Marina NM; Lauer SJ; Olson TA; Rogers PC; Colombani P; Rescorla F; Billmire DF; Vinocur CD; Hawkins EP; Davis MM; Perlman EJ; London WB; Castleberry RP; ;
    J Clin Oncol; 2004 Jul; 22(13):2691-700. PubMed ID: 15226336
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The role of enzymuria in evaluation of the nephrotoxicity of antineoplastic chemotherapy in children].
    Liubimova NV; Kumykova ZhKh; Kushlinskiĭ NE; Mentkevich GL; Valenteĭ LV; Durnov LA
    Biull Eksp Biol Med; 1997 Oct; 124(10):446-50. PubMed ID: 9410181
    [No Abstract]   [Full Text] [Related]  

  • 40. Role of ellagic acid against cisplatin-induced nephrotoxicity and oxidative stress in rats.
    Ateşşahín A; Ceríbaşi AO; Yuce A; Bulmus O; Cikim G
    Basic Clin Pharmacol Toxicol; 2007 Feb; 100(2):121-6. PubMed ID: 17244261
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.